One in four Americans say they don’t want a coronavirus vaccine. That’s according
to a recent poll by NPR and Marist. Misinformation could be one cause, including posts and stories that are shared on social media.
Researchers at Virginia Tech are looking at how this is playing out with people in Appalachia. It’s called, “Trust in Healthcare and
The researchers asked a group of Appalachians who they trusted the most from a list of 15 healthcare-related choices. According to Dr. Michelle Rockwell, lead investigator on the project, most people surveyed said they trusted a primary care doctor.
“We are interested in knowing if there are any subtle interventions that a healthcare provider or healthcare organization could take to help with the spread of misinformation,” Rockwell said. “We designed a social media simulation based on some other work that has shown that little nudges, thinking through accuracy, before reading, social media can make a difference in how tha
Candidate coronavirus vaccines show promising results in early animal testing
A candidate vaccine that could provide protection against the COVID-19 virus and other coronaviruses has shown promising results in early animal testing.
The candidate coronavirus vaccines, created by Virginia Tech s University Distinguished Professor X.J. Meng and UVA Health s Professor Steven L. Zeichner, prevented pigs from being becoming ill with a pig coronavirus, porcine epidemic diarrhea virus (PEDV).
The researchers have recently published their findings in the
Proceedings of the National Academy of Sciences.
The candidate vaccine was developed using an innovative vaccine platform targeting a highly conserved genomic region of coronaviruses. The new vaccine platform utilizes a genome-reduced bacteria to express the coronavirus vaccine antigen on its surface. Such a vaccine platform can be manufactured with low cost in existing facilities around the world, which could meet the pandemic demand.
E-Mail
IMAGE: X.J. Meng, University Distinguished Professor in the Virginia-Maryland College of Veterinary Medicine and founding director of the new center tackling infectious disease in the Fralin Life Sciences Institute at Virginia. view more
Credit: Virginia Tech
A candidate vaccine that could provide protection against the COVID-19 virus and other coronaviruses has shown promising results in early animal testing.
The candidate coronavirus vaccines, created by Virginia Tech s University Distinguished Professor X.J. Meng and UVA Health s Professor Steven L. Zeichner, prevented pigs from being becoming ill with a pig coronavirus, porcine epidemic diarrhea virus (PEDV).
The researchers have recently published their findings in the
Primary Care Providers Could Be Key To COVID19 Vaccine Rollout In Appalachian Communities wvpublic.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wvpublic.org Daily Mail and Mail on Sunday newspapers.
Dr. Karen Shelton watches as cases of COVID-19 begin again to rise in Virginiaâs Appalachian counties.
She needs more vaccine. And sheâll need more people willing to roll up their sleeves to take it.
At the moment, Shelton, who directs public health for everyone living west of the New River Valley, doesnât have enough doses to meet the demand. Her region was hit especially hard over the fall and winter, with the virus killing more than 800 people. The local hospital system became so overwhelmed that it had to curtail all but critical medical care, create new intensive care units and park morgue trucks outside its flagship hospitals.